Demerol meperidine market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to fuel the growth of the market during the forecast period include the growth in the incidence of infectious diseases & chronic pain and a rise in disposable income and a surge in the geriatric population. However, the emergence and legalization of alternative treatments of opioids such as cannabis impede the growth of the market. Moreover, the growing demand for meperidine associated with its higher usage as an anaesthetic in different surgical procedures is expected to drive the global meperidine (demerol) market growth. For instance, according to the World Health Organization (WHO) 2021, it is estimated that 143 million surgical procedures are required across the world each year to save lives and prevent disability. This, in turn, is driving the demand for demerol meperidine as it used before and during surgery with other kinds of pain medication.
Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. Meperidine is used to treat moderate-to-severe pain. In addition, the increasing incidence of cancer across the globe is expected to drive the global Meperidine (Demerol) market. For instance, according to National Cancer Institute, it was estimated that 1,806,590 new cases of cancer would be diagnosed in the US and 606,520 people would die from the disease in 2020. This results in increasing demand for demerol (meperidine) for cancer patients as it is used for the treatment of moderate to severe pain. However, there are several concerns about adverse reactions, drug interactions, and normeperidine neurotoxicity which hamper the market growth
To Request a Sample of our Report on Demerol Meperidine Market: https://www.omrglobal.com/request-sample/demerol-meperidine-market
Market Coverage
- The market number available for – 2022-2029
- Base year- 2022
- Forecast period- 2023-2029
Segment Covered-
- By Product Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Boehringer Ingelheim GmbH, Pfizer Inc., and Sanofi S.A., among others.
Demerol Meperidine Market Report by Segment
By Product Type
- Powder
- Liquid
By Application
- Anaesthesia
- Cough Treatment
- Diarrhoea Treatment
A full Report of Demerol Meperidine Market is Available @ https://www.omrglobal.com/industry-reports/demerol-meperidine-market
Demerol Meperidine Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/demerol-meperidine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
